Public Comments
CTAF

PDF cover

CAR-T Therapies: Public Comment on Draft Evidence Report

Public comments on the Draft Evdience Report reviewing tisagenlecleucel (KymriahTM, Novartis) and axicabtagene ciloleucel (YescartaTM, Kite Pharma/Gilead).

View

View All Materials on this Topic or Go Back to View More Materials